Clinical Trial Update: Safety, Tolerability, PK and PD of ADX-850 in Participants With Hypertension [Phase 1]

View source ↗

Summary

An early Phase 1 study assessing the safety, tolerability, pharmacokinetics and pharmacodynamics of ADX-850 in participants with hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension
• Hypertension

Drugs mentioned

• ADX-850

Snippet

Sponsor: ADARx Pharmaceuticals, Inc. | Conditions: Hypertension, Hypertension,Essential | Phase 1 | Status: ACTIVE_NOT_RECRUITING